← Back to Clinical Trials
Recruiting NCT04570163

Berlin Registry of Right Heart Interventions

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Tricuspid Regurgitation
Sponsor Charite University, Berlin, Germany
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age 120 Years
Start Date 2020-06-16
Completion 2035-12-31
Interventions
Interventional therapy mainly of tricuspid regurgitation (TriClip, Cardioband)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The present study evaluates patients after interventional therapy of valvular diseases of the right heart. Follow-up examinations include medical history taking, laboratory measurements and an echo. The aim is to assess the different interventional therapies and their impact on patient's outcome.

Eligibility Criteria

Inclusion Criteria: * Patients with planned or recent valve interventions of the right heart (tricuspid regurgitation/ stenosis, pulmonary regurgitation/ stenosis) * \>18 years * Written, documented consent Exclusion Criteria: * Patients in care or unable to consent * Patients who are unable to comply with follow-up examinations * Patients who are detained in an institution

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE TRICUSPID REGURGITATION TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}